Categories: Business

President Biden meets with CEOs from J&J and Merck

[The stream is slated to start at 3 p.m. ET. Please refresh the page if you do not see a player above at that time.]

President Joe Biden will meet at the White House on Wednesday with Kenneth Frazier, Chairman and CEO of Merck, and Alex Gorsky, Chairman and CEO of Johnson & Johnson.

On Wednesday, the Biden government announced that it plans to purchase an additional 100 million doses of the Covid-19 vaccine from J&J. The deal would double the country’s supply of the J&J vaccine as the company has already signed a deal with the government to provide 100 million doses by the end of June.

Last week, Biden announced that Merck would help manufacture J & J’s Covid vaccine. As part of the agreement, Merck will set up two facilities in the United States to manufacture the cans. One will make the vaccine and the other will provide “fill-finish” services when the vaccine is put into vials.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Jimmy Page

MV Telegraph Writer Jimmy Page has been writing for all these 37 years.

Recent Posts

Eli Lilly reaches deal to carry AI-developed medication to international market

A drone view shows the Eli Lilly logo on the company's office in San Diego,…

1 day ago

WTI and Brent as merchants assess Trump’s feedback on Iran struggle

A general view of the oil terminal of Kharg Island, 25 km from the Iranian…

1 day ago

The worth of Pokémon playing cards will increase through the Logan Paul Pikachu public sale

Pokémon cards are no longer just childhood collectibles.Some owners are increasingly treating the popular trading…

2 days ago

Epstein victims obtain $72.5 million in settlement with Financial institution of America

A Bank of America branch in New York, USA, on Saturday, October 11, 2025. Michael…

3 days ago

Miss Thailand Contestant’s Enamel Fall Out: Video

But she's not the only star to suffer a dental accident on stage. Just ask…

5 days ago

Pfizer’s Lyme illness vaccine fails trial, firm applies for FDA approval

Thomas Fuller | Photo only | Getty ImagesPfizer On Monday, the company said it would…

6 days ago

This website uses cookies.